OBSESSIVE-COMPULSIVE DISORDER
Clinical trials for OBSESSIVE-COMPULSIVE DISORDER explained in plain language.
Never miss a new study
Get alerted when new OBSESSIVE-COMPULSIVE DISORDER trials appear
Sign up with your email to follow new studies for OBSESSIVE-COMPULSIVE DISORDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New study: can pills plus therapy boost recovery for mental illness?
Disease control OngoingThis study looks at whether adding cognitive behavioral therapy (a type of talk therapy) to standard medication can improve symptoms and daily functioning for people with conditions like anxiety, depression, OCD, PTSD, bipolar disorder, schizophrenia, and personality disorders. A…
Matched conditions: OBSESSIVE-COMPULSIVE DISORDER
Phase: PHASE1 • Sponsor: Rakitzi, Stavroula • Aim: Disease control
Last updated May 26, 2026 05:02 UTC
-
Brain zaps for OCD: tiny trial hopes to tame obsessions
Disease control OngoingThis study tests a brain implant (deep brain stimulation) in 2 people with severe obsessive-compulsive disorder (OCD) that hasn't improved with standard treatments. The device sends electrical pulses to specific brain areas to help control symptoms. The goal is to reduce OCD seve…
Matched conditions: OBSESSIVE-COMPULSIVE DISORDER
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
Magic mushroom therapy targets tough OCD cases
Symptom relief ENROLLING_BY_INVITATIONThis early-stage study tests whether psilocybin, the active ingredient in magic mushrooms, given alongside psychotherapy can safely reduce symptoms in people with obsessive-compulsive disorder (OCD) that hasn't responded to standard treatments. Ten adults will receive two 25 mg d…
Matched conditions: OBSESSIVE-COMPULSIVE DISORDER
Phase: PHASE1 • Sponsor: Centre for Addiction and Mental Health • Aim: Symptom relief
Last updated May 26, 2026 05:02 UTC
-
Could a Parkinson's drug tame OCD symptoms?
Symptom relief OngoingThis study tests whether tolcapone, a drug currently used for Parkinson's disease, can safely reduce symptoms in adults with moderate to severe obsessive-compulsive disorder (OCD). About 49 participants will receive either tolcapone or a placebo to compare changes in OCD severity…
Matched conditions: OBSESSIVE-COMPULSIVE DISORDER
Phase: PHASE2 • Sponsor: University of Chicago • Aim: Symptom relief
Last updated May 26, 2026 04:38 UTC
-
OCD breakthrough? Anti-Inflammatory drug targets brain inflammation in new study
Symptom relief TerminatedThis study looked at whether measuring brain inflammation with scans and blood tests could predict how much people with obsessive-compulsive disorder (OCD) would benefit from adding the anti-inflammatory drug celecoxib to their current medication. The goal was to see if a persona…
Matched conditions: OBSESSIVE-COMPULSIVE DISORDER
Phase: PHASE2 • Sponsor: New York State Psychiatric Institute • Aim: Symptom relief
Last updated May 26, 2026 04:36 UTC
-
Magic mushroom compound tested for OCD: early trial shows promise
Symptom relief OngoingThis early-stage study is testing whether repeated doses of psilocybin, the active ingredient in magic mushrooms, can reduce symptoms of obsessive-compulsive disorder (OCD). The trial involves 30 adults with severe OCD who have not responded well to standard treatments. Researche…
Matched conditions: OBSESSIVE-COMPULSIVE DISORDER
Phase: PHASE1 • Sponsor: Yale University • Aim: Symptom relief
Last updated May 26, 2026 04:34 UTC
-
Hospital tests Non-Doctors for therapy: surprising results?
Symptom relief OngoingThis study looks at whether unlicensed professionals can successfully give cognitive behavioral therapy (CBT) to patients in a general hospital. About 250 adults with conditions like anxiety, depression, OCD, or PTSD will take part. The goal is to see if this approach improves ps…
Matched conditions: OBSESSIVE-COMPULSIVE DISORDER
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated May 22, 2026 14:05 UTC
-
Nature therapy may soothe anxiety, early study hints
Symptom relief OngoingThis study explores whether a new type of group therapy, called natural psychotherapy, can help people with anxiety disorders. Sixty adults aged 15 to 55 with obsessive-compulsive disorder will take part. The therapy is based on Eastern culture and aims to reduce anxiety symptoms…
Matched conditions: OBSESSIVE-COMPULSIVE DISORDER
Phase: NA • Sponsor: Beijing HuiLongGuan Hospital • Aim: Symptom relief
Last updated May 22, 2026 14:04 UTC
-
Brain zaps boost OCD therapy in teens?
Symptom relief OngoingThis study tests if a non-invasive brain stimulation technique called TMS can improve the effects of exposure therapy for teens and young adults with OCD. Fifty participants aged 12 to 21 will receive either real or fake TMS before therapy sessions for two weeks. Researchers will…
Matched conditions: OBSESSIVE-COMPULSIVE DISORDER
Phase: NA • Sponsor: Bradley Hospital • Aim: Symptom relief
Last updated May 22, 2026 13:51 UTC
-
Shock therapy without the shock: new hope for OCD?
Symptom relief OngoingThis study tests a non-invasive brain stimulation method called tDCS for people with obsessive-compulsive disorder (OCD) who haven't gotten better with standard treatments like therapy or antidepressants. About 43 participants will receive low-level electrical current through ele…
Matched conditions: OBSESSIVE-COMPULSIVE DISORDER
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Symptom relief
Last updated May 18, 2026 12:13 UTC
-
Magic mushroom compound tested for OCD relief
Symptom relief OngoingThis early-phase study tests whether psilocybin, the active ingredient in magic mushrooms, can safely help reduce symptoms of obsessive-compulsive disorder (OCD). Thirty-five adults with OCD who have not responded well to standard treatments will receive psilocybin in a controlle…
Matched conditions: OBSESSIVE-COMPULSIVE DISORDER
Phase: EARLY_PHASE1 • Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated May 18, 2026 12:01 UTC
-
Mindfulness may ease OCD symptoms in major new trial
Symptom relief OngoingThis study tests whether a short mindfulness program can reduce the distress of obsessive-compulsive disorder (OCD). About 420 adults with OCD will receive either mindfulness training or standard therapy. Researchers will measure changes in OCD symptoms and explore how mindfulnes…
Matched conditions: OBSESSIVE-COMPULSIVE DISORDER
Phase: NA • Sponsor: Sunnybrook Health Sciences Centre • Aim: Symptom relief
Last updated May 11, 2026 20:39 UTC
-
OCD brain implant study pulled before it began
Knowledge-focused TerminatedThis study was designed to find better ways to place deep brain stimulation (DBS) electrodes in patients with severe obsessive-compulsive disorder (OCD). The goal was to use brain scans to personalize targeting and improve symptom relief. However, the study was withdrawn before e…
Matched conditions: OBSESSIVE-COMPULSIVE DISORDER
Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated May 26, 2026 05:08 UTC
-
Brain scans may hold key to personalized OCD therapy
Knowledge-focused OngoingThis study from Stanford University looks at whether brain imaging can identify different types of OCD and predict how well patients respond to a non-invasive brain stimulation treatment called rTMS. Researchers will test two different brain targets in 212 adults with moderate to…
Matched conditions: OBSESSIVE-COMPULSIVE DISORDER
Phase: NA • Sponsor: Stanford University • Aim: Knowledge-focused
Last updated May 26, 2026 05:07 UTC
-
Lab-Grown brain cells could unlock personalized OCD treatments
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at 60 people with obsessive-compulsive disorder (OCD) who either respond well to medication or brain stimulation, or don't respond at all. Researchers will take blood samples and turn them into nerve cells in the lab to study how these cells react to treatments. …
Matched conditions: OBSESSIVE-COMPULSIVE DISORDER
Phase: NA • Sponsor: ASST Fatebenefratelli Sacco • Aim: Knowledge-focused
Last updated May 26, 2026 04:59 UTC
-
Teen therapy showdown: which talk treatment works best?
Knowledge-focused ENROLLING_BY_INVITATIONThis study watches 192 teens aged 12–20 who are already getting therapy for anxiety, depression, or OCD. Researchers will compare Cognitive Behavioral Therapy (CBT) and Brief Strategic Therapy (BST) to see which helps more with symptoms, self-esteem, and quality of life. No new t…
Matched conditions: OBSESSIVE-COMPULSIVE DISORDER
Sponsor: IRCCS Centro Neurolesi Bonino Pulejo • Aim: Knowledge-focused
Last updated May 26, 2026 04:59 UTC
-
Can one therapy treat all anxieties? new study tests the idea
Knowledge-focused OngoingThis study explores whether a single type of therapy (transdiagnostic CBT) can work as well as different therapies tailored to specific anxiety disorders like panic disorder or social anxiety. Researchers will check if it's possible to run a larger trial by looking at how many pe…
Matched conditions: OBSESSIVE-COMPULSIVE DISORDER
Phase: NA • Sponsor: Karolinska Institutet • Aim: Knowledge-focused
Last updated May 26, 2026 04:38 UTC
-
Brain implant learns to detect OCD symptoms in real time
Knowledge-focused OngoingThis study is for people with severe, hard-to-treat OCD. Researchers are testing an advanced brain stimulation system that can adapt to a person's needs. The goal is to find brain signals linked to OCD distress and improve how deep brain stimulation works. Only 2 people will take…
Matched conditions: OBSESSIVE-COMPULSIVE DISORDER
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Knowledge-focused
Last updated May 22, 2026 14:02 UTC
-
Brain-Controlled device could revolutionize OCD treatment
Knowledge-focused OngoingThis study is for people with severe, hard-to-treat obsessive-compulsive disorder (OCD). Researchers are testing a new type of deep brain stimulation that uses the brain's own signals to automatically adjust the electrical pulses. The goal is to improve symptom control and reduce…
Matched conditions: OBSESSIVE-COMPULSIVE DISORDER
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Knowledge-focused
Last updated May 20, 2026 11:58 UTC